1: Chopra A. [18F]-N-{4-[(4,5-Dichloro-2-fluorophenyl)amino]qu inazoline-6-yl}-dimethylamine-butylamide. 2009 Jun 26 [updated 2009 Aug 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641684.
2: Kirjavainen AK, Forsback S, López-Picón FR, Marjamäki P, Takkinen J, Haaparanta-Solin M, Peters D, Solin O. 18F-labeled norepinephrine transporter tracer [18F]NS12137: radiosynthesis and preclinical evaluation. Nucl Med Biol. 2018 Jan;56:39-46. doi: 10.1016/j.nucmedbio.2017.10.005. Epub 2017 Oct 24. PMID: 29172120.
3: Liu F, Zhao B, Xia XT, Yan JR, Yu FQ, Yan GP, Hu J, Chen S, Wang YF, Liu H, Lan XL, Zhang YX. Al18 F labeled sulfonamide-conjugated positron emission tomography tracer in vivo tumor-targeted imaging. J Cell Biochem. 2019 Oct;120(10):17006-17014. doi: 10.1002/jcb.28961. Epub 2019 May 26. PMID: 31131464.
4: The MICAD Research Team. 3-{4-[2-[Benzoxazol-2-yl- methylamino]ethoxy]phenyl}-2-(2-[18F]fluoroethoxy)propionic acid. 2007 Apr 2 [updated 2007 May 15]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641433.
5: Tseng CH, Lin CK, Chen YL, Tseng CK, Lee JY, Lee JC. Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression. Eur J Med Chem. 2018 Jan 1;143:970-982. doi: 10.1016/j.ejmech.2017.12.006. Epub 2017 Dec 5. PMID: 29232587.
6: Goud NS, Kanth Makani VK, Pranay J, Alvala R, Qureshi IA, Kumar P, Bharath RD, Nagaraj C, Yerramsetty S, Pal-Bhadra M, Alvala M. Synthesis, 18F-radiolabeling and apoptosis inducing studies of novel 4, 7-disubstituted coumarins. Bioorg Chem. 2020 Apr;97:103663. doi: 10.1016/j.bioorg.2020.103663. Epub 2020 Feb 25. PMID: 32106038.
7: Tietz O, Marshall A, Bergman C, Wuest M, Wuest F. Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents. Nucl Med Biol. 2018 Jul- Aug;62-63:9-17. doi: 10.1016/j.nucmedbio.2018.05.001. Epub 2018 May 5. PMID: 29800798.
8: Declercq L, Rombouts F, Koole M, Fierens K, Mariën J, Langlois X, Andrés JI, Schmidt M, Macdonald G, Moechars D, Vanduffel W, Tousseyn T, Vandenberghe R, Van Laere K, Verbruggen A, Bormans G. Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging. J Nucl Med. 2017 Jun;58(6):975-981. doi: 10.2967/jnumed.116.185199. Epub 2017 Feb 23. PMID: 28232614.
9: Cantore M, Benadiba M, Elsinga PH, Kwizera C, Dierckx RA, Colabufo NA, Luurtsema G. (11)C- and (18)F-Labeled Radioligands for P-Glycoprotein Imaging by Positron Emission Tomography. ChemMedChem. 2016 Jan 5;11(1):108-18. doi: 10.1002/cmdc.201500420. Epub 2015 Nov 13. PMID: 26563728.
10: Betts HM, Robins EG. 2-Bromo-6-[(18) F]fluoropyridine: two-step fluorine-18 radiolabelling via transition metal-mediated chemistry. J Labelled Comp Radiopharm. 2014 Apr;57(4):215-8. doi: 10.1002/jlcr.3147. Epub 2013 Dec 18. PMID: 24347378.
11: Smith G, Zhao Y, Leyton J, Shan B, Nguyen QD, Perumal M, Turton D, Årstad E, Luthra SK, Robins EG, Aboagye EO. Radiosynthesis and pre-clinical evaluation of [(18)F]fluoro-[1,2-(2)H(4)]choline. Nucl Med Biol. 2011 Jan;38(1):39-51. doi: 10.1016/j.nucmedbio.2010.06.012. Epub 2010 Sep 1. PMID: 21220128.
12: Kanthala SP, Liu YY, Singh S, Sable R, Pallerla S, Jois SD. A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization. Oncotarget. 2017 Jul 5;8(43):74244-74262. doi: 10.18632/oncotarget.19013. PMID: 29088782; PMCID: PMC5650337.
13: Bouvet V, Wuest M, Bailey JJ, Bergman C, Janzen N, Valliant JF, Wuest F. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile. Mol Imaging Biol. 2017 Dec;19(6):923-932. doi: 10.1007/s11307-017-1102-x. PMID: 28639122.
14: Zhang S, Wang X, He Y, Ding R, Liu H, Xu J, Feng M, Li G, Wang M, Peng C, Qi C. (18)F Labeled benzimidazole derivatives as potential radiotracer for positron emission tomography (PET) tumor imaging. Bioorg Med Chem. 2010 Apr 1;18(7):2394-401. doi: 10.1016/j.bmc.2010.02.060. Epub 2010 Mar 6. PMID: 20303769.
15: Claesener M, Breyholz HJ, Hermann S, Faust A, Wagner S, Schober O, Schäfers M, Kopka K. Efficient synthesis of a fluorine-18 labeled biotin derivative. Nucl Med Biol. 2012 Nov;39(8):1189-94. doi: 10.1016/j.nucmedbio.2012.08.001. Epub 2012 Sep 19. PMID: 22998841.
16: Gomez-Sanchez CE, Kirk DN, Farrant RD, Milewich L. 18-Substituted steroids: synthesis of 18-hydroxycortisol (11 beta,17 alpha,18,21-tetrahydroxy-4-pregnene-3,20-dione) and 18-hydroxycortisone (17 alpha,18,21-trihydroxy-4-pregnene-3,11,20-trione). J Steroid Biochem. 1985 Jan;22(1):141-6. doi: 10.1016/0022-4731(85)90154-2. PMID: 3974224.
17: Billaud EMF, Belderbos S, Cleeren F, Maes W, Van de Wouwer M, Koole M, Verbruggen A, Himmelreich U, Geukens N, Bormans G. Pretargeted PET Imaging Using a Bioorthogonal 18F-Labeled trans-Cyclooctene in an Ovarian Carcinoma Model. Bioconjug Chem. 2017 Dec 20;28(12):2915-2920. doi: 10.1021/acs.bioconjchem.7b00635. Epub 2017 Dec 11. PMID: 29191024.
18: Pallerla S, Naik H, Singh S, Gauthier T, Sable R, Jois SD. Design of cyclic and d-amino acids containing peptidomimetics for inhibition of protein-protein interactions of HER2-HER3. J Pept Sci. 2018 Feb;24(2):10.1002/psc.3066. doi: 10.1002/psc.3066. PMID: 29436155; PMCID: PMC6284401.
19: Moldovan RP, Wenzel B, Teodoro R, Neumann W, Dukic-Stefanovic S, Kraus W, Rong P, Deuther-Conrad W, Hey-Hawkins E, Krügel U, Brust P. Studies towards the development of a PET radiotracer for imaging of the P2Y1 receptors in the brain: synthesis, 18F-labeling and preliminary biological evaluation. Eur J Med Chem. 2019 Mar 1;165:142-159. doi: 10.1016/j.ejmech.2019.01.006. Epub 2019 Jan 7. PMID: 30665144.
20: Carberry P, Lieberman BP, Ploessl K, Choi SR, Haase DN, Kung HF. New F-18 prosthetic group via oxime coupling. Bioconjug Chem. 2011 Apr 20;22(4):642-53. doi: 10.1021/bc1004262. Epub 2011 Mar 31. PMID: 21452846; PMCID: PMC3086766.